» Articles » PMID: 32949122

Crohn's Disease: Is the Cold Chain Hypothesis Still Hot?

Overview
Date 2020 Sep 19
PMID 32949122
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Crohn's disease [CD] is an inflammatory bowel disease of unknown aetiology. During recent decades, significant technological advances led to development of -omic datasets allowing a detailed description of the disease. Unfortunately these have not, to date, resolved the question of the aetiology of CD. Thus, it may be necessary to [re]consider hypothesis-driven approaches to resolve the aetiology of CD. According to the cold chain hypothesis, the development of industrial and domestic refrigeration has led to frequent exposure of human populations to bacteria capable of growing in the cold. These bacteria, at low levels of exposure, particularly those of the genus Yersinia, are believed to be capable of inducing exacerbated inflammation of the intestine in genetically predisposed subjects. We discuss the consistency of this working hypothesis in light of recent data from epidemiological, clinical, pathological, microbiological, and molecular studies.

Citing Articles

Endoscopic and video capsule endoscopic observation of enterocolitis.

Marubashi K, Takagi H, Wakagi T, Takakusagi S, Yokoyama Y, Kizawa K DEN Open. 2023; 3(1):e242.

PMID: 37125071 PMC: 10140541. DOI: 10.1002/deo2.242.


Cold stress induces colitis-like phenotypes in mice by altering gut microbiota and metabolites.

Sun L, Wang X, Zou Y, He Y, Liang C, Li J Front Microbiol. 2023; 14:1134246.

PMID: 37113236 PMC: 10126409. DOI: 10.3389/fmicb.2023.1134246.


Yersinia enterocolitica in Crohn's disease.

Fang X, Kang L, Qiu Y, Li Z, Bai Y Front Cell Infect Microbiol. 2023; 13:1129996.

PMID: 36968108 PMC: 10031030. DOI: 10.3389/fcimb.2023.1129996.


Yersiniosis in New Zealand.

Rivas L, Strydom H, Paine S, Wang J, Wright J Pathogens. 2021; 10(2).

PMID: 33578727 PMC: 7916520. DOI: 10.3390/pathogens10020191.

References
1.
Gasche C, Nemeth M, Grundtner P, Willheim-Polli C, Ferenci P, Schwarzenbacher R . Evolution of Crohn's disease-associated Nod2 mutations. Immunogenetics. 2008; 60(2):115-20. DOI: 10.1007/s00251-008-0274-6. View

2.
Liu J, van Sommeren S, Huang H, Ng S, Alberts R, Takahashi A . Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015; 47(9):979-986. PMC: 4881818. DOI: 10.1038/ng.3359. View

3.
Ogura Y, Bonen D, Inohara N, Nicolae D, Chen F, Ramos R . A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411(6837):603-6. DOI: 10.1038/35079114. View

4.
Logan M, Gkikas K, Svolos V, Nichols B, Milling S, Gaya D . Analysis of 61 exclusive enteral nutrition formulas used in the management of active Crohn's disease-new insights into dietary disease triggers. Aliment Pharmacol Ther. 2020; 51(10):935-947. PMC: 8653890. DOI: 10.1111/apt.15695. View

5.
Ananthakrishnan A, Khalili H, Song M, Higuchi L, Richter J, Chan A . Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Int J Epidemiol. 2015; 44(6):1995-2005. PMC: 5156337. DOI: 10.1093/ije/dyv301. View